IQVIA Holdings Inc. (IQV) Insider Trading

Last 12 months

Insiders sold $51.4M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. See Remarks Ari Bousbib sold $26.1M on Jul 29, 7.2% of their stake, outside a plan. The last open-market buy by an executive or director was in Dec 2024.

Net open-market

−$51.4M

0 buys · 9 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 6

executives and directors

Last open-market buy

Dec 2024

Dec 3, 2024

Get an email when IQV's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 2	James G. Berkshire See Remarks	SoldNo plan	2,668	$261.33	$697k	25%	Form 4
Aug 3	W Richard Staub See Remarks	SoldNo plan	5,500	$232.68	$1.28M	29%	Form 4
Jul 31	Bhavik Patel See Remarks	SoldNo plan	1,855	$235.27	$436k	58%	Form 4
Jul 29	Eric Sherbet See Remarks	SoldNo plan	5,000	$249.16	$1.25M	19%	Form 4
Jul 29	Keriann Cherofsky See Remarks	SoldNo plan	558	$245.21	$137k	16%	Form 4
Jul 29	Ari Bousbib See Remarks	SoldNo plan 4 parts	106,279	$245.51 average	$26.1M	7.2%	Form 4
Dec 18, 2025	Ari Bousbib See Remarks	SoldNo plan	36,564	$222.43	$8.13M	2.6%	Form 4
Oct 29, 2025	Eric Sherbet See Remarks	SoldNo plan	4,000	$219.70	$879k	16%	Form 4
Oct 29, 2025	Ari Bousbib See Remarks	SoldNo plan 6 parts	56,557	$220.33 average	$12.5M	4.0%	Form 4
Jul 23, 2025	Keriann Cherofsky See Remarks	SoldNo plan	549	$191.53	$105k	16%	Form 4
Jul 23, 2025	Eric Sherbet See Remarks	SoldNo plan	5,800	$190.05	$1.1M	22%	Form 4
Dec 3, 2024	John G Danhakl Director	Bought	1,275	$200.58	$256k	4.6%	Form 4

Sep 2No plan
James G. Berkshire
See Remarks · sold 2,668 at $261.33
$697k
25% of stake
Aug 3No plan
W Richard Staub
See Remarks · sold 5,500 at $232.68
$1.28M
29% of stake
Jul 31No plan
Bhavik Patel
See Remarks · sold 1,855 at $235.27
$436k
58% of stake
Jul 29No plan
Eric Sherbet
See Remarks · sold 5,000 at $249.16
$1.25M
19% of stake
Jul 29No plan
Keriann Cherofsky
See Remarks · sold 558 at $245.21
$137k
16% of stake
Jul 29No plan
Ari Bousbib
See Remarks · sold 106,279 at avg $245.51
$26.1M
7.2% of stake
Dec 18, 2025No plan
Ari Bousbib
See Remarks · sold 36,564 at $222.43
$8.13M
2.6% of stake
Oct 29, 2025No plan
Eric Sherbet
See Remarks · sold 4,000 at $219.70
$879k
16% of stake
Oct 29, 2025No plan
Ari Bousbib
See Remarks · sold 56,557 at avg $220.33
$12.5M
4.0% of stake
Jul 23, 2025No plan
Keriann Cherofsky
See Remarks · sold 549 at $191.53
$105k
16% of stake
Jul 23, 2025No plan
Eric Sherbet
See Remarks · sold 5,800 at $190.05
$1.1M
22% of stake
Dec 3, 2024
John G Danhakl
Director · bought 1,275 at $200.58
$256k
4.6% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IQV, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Commercial Physical & Biological Research

INCYIncyte Corporation

CRLCharles River Laboratories International, Inc.

MEDPMedpace Holdings Inc.

ULSUl Solutions Inc.

ACMAecom

BAHBooz Allen Hamilton Holding Corporation

PAYXPaychex Inc.

ITGartner Inc.

Spot a number that looks wrong? Check it in IQV's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IQV

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.